Ascending Triangle formed into an Uptrend Corridor and new support confirmed multiple times on the 5-min chart on 25th Aug.
About the entry, you have two options. Chasing the price entering with a Buy Stop order or waiting for a better entry with a Buy Limit. It comes down to your appetite for risk and current trade situation - I will most likely go ahead with a safer Limit order.
Note that the success of this trade highly depends on COVID19-related news, and to AZN's vaccine development.
Target price set at resistance line bounce.
- Historical Uptrend
- RSI and STOCH above 50
- MACD above Signal
Suggested Entry $96.86 (Stop) or $95.72 (Limit)
Suggested Stop Loss $92.42
Target price $111.36
Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss.
About the entry, you have two options. Chasing the price entering with a Buy Stop order or waiting for a better entry with a Buy Limit. It comes down to your appetite for risk and current trade situation - I will most likely go ahead with a safer Limit order.
Note that the success of this trade highly depends on COVID19-related news, and to AZN's vaccine development.
Target price set at resistance line bounce.
- Historical Uptrend
- RSI and STOCH above 50
- MACD above Signal
Suggested Entry $96.86 (Stop) or $95.72 (Limit)
Suggested Stop Loss $92.42
Target price $111.36
Note that I tend to adjust stop losses in order to secure profits early and preserve capital. This means that the target price is going to be achieved as long as there are no strong pullbacks that trigger my new adjusted stop loss.
Trade active
Trade closed: target reached
4.44% profit
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.